Literature DB >> 21886390

Transfusion associated graft versus host disease following whole blood transfusion from an unrelated donor in an immunocompetent patient.

Ketan K Patel, Atul K Patel, Rajiv R Ranjan, Apurva P Shah.   

Abstract

Graft-versus-host disease (GVHD) is a well-known complication of allogeneic bone marrow transplantation. Transfusion associated graft-versus-host disease (TA-GVHD) is much less common and nearly uniformly fatal complication of blood transfusion. The risk factors underlying the development of TA- GVHD are incompletely defined, but it is commonly seen in individuals with congenital or acquired immunodeficiency, transfusions from blood relatives, intrauterine transfusions and HLA-matched platelet transfusions. Diagnosis of TA-GVHD may be difficult at a time due to rarity in occurrence and overlapping clinical features with various infections and drug reactions. We describe a case of transfusion-associated GVHD that occurred after transfusion of whole blood from unrelated donor in an immunocompetent patient.

Entities:  

Keywords:  Blood transfusion; Graft versus host disease; TA-GVHD

Year:  2010        PMID: 21886390      PMCID: PMC3002081          DOI: 10.1007/s12288-010-0028-0

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  13 in total

Review 1.  Transfusion-associated graft-versus-host disease.

Authors:  Marlis L Schroeder
Journal:  Br J Haematol       Date:  2002-05       Impact factor: 6.998

Review 2.  Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients.

Authors:  H Ohto; K C Anderson
Journal:  Transfus Med Rev       Date:  1996-01

3.  Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells.

Authors:  Darrell Triulzi; Rene Duquesnoy; Lawrence Nichols; Kenneth Clark; Drazen Jukic; Adriana Zeevi; Dennis Meisner
Journal:  Transfusion       Date:  2006-06       Impact factor: 3.157

4.  Effects of surgery, anesthesia and intraoperative blood loss on immunocompetence.

Authors:  A V Jubert; E T Lee; E M Hersh; C M McBride
Journal:  J Surg Res       Date:  1973-12       Impact factor: 2.192

5.  Transfusion-associated graft-versus-host disease.

Authors:  D B Brubaker
Journal:  Hum Pathol       Date:  1986-11       Impact factor: 3.466

Review 6.  Graft versus host disease following transfusion of normal blood products to patients with malignancies.

Authors:  A Kessinger; J O Armitage; L W Klassen; J D Landmark; J M Hayes; A E Larsen; D T Purtilo
Journal:  J Surg Oncol       Date:  1987-11       Impact factor: 3.454

7.  [Probable graft-versus-host reaction following massive blood transfusion in an aged patient with postoperative aortic aneurysm: a case report].

Authors:  Y Aoki; H Nakamura; Y Sakakibara
Journal:  Nihon Naika Gakkai Zasshi       Date:  1984-08

8.  Diagnostic features of transfusion associated graft versus host disease.

Authors:  A L Appleton; L Sviland; A D Pearson; J Wilkes; M A Green; A J Malcolm
Journal:  J Clin Pathol       Date:  1994-06       Impact factor: 3.411

Review 9.  Transfusion-associated graft-versus-host disease.

Authors:  D M Dwyre; P V Holland
Journal:  Vox Sang       Date:  2008-06-09       Impact factor: 2.144

Review 10.  Transfusion-associated graft-versus-host disease.

Authors:  J M Rappeport
Journal:  Yale J Biol Med       Date:  1990 Sep-Oct
View more
  3 in total

1.  TA-GVHD, a Fatal Complication Following Blood Transfusion from a First-Degree Relative.

Authors:  Subbalaxmi V S Malladi; Roshni Paul; Naval Chandra; Nageswara Modugu Rao; Satyanarayana Yadati Raju
Journal:  J Obstet Gynaecol India       Date:  2012-10-03

2.  Transfusion Associated Graft Versus Host Disease.

Authors:  Kikkeri Narayanshetty Naveen; Sharatchandra B Athanker; Umesh Rajoor; Jayaraj Sindhoor
Journal:  Indian J Dermatol       Date:  2015 May-Jun       Impact factor: 1.494

3.  Prevention of transfusion-associated graft-versus-host disease by irradiation: technical aspect of a new ferrous sulphate dosimetric system.

Authors:  Lucas Sacchini Del Lama; Evamberto Garcia de Góes; Paulo César Dias Petchevist; Edson Lara Moretto; José Carlos Borges; Dimas Tadeu Covas; Adelaide de Almeida
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.